Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.6900 (-2.89%) ($120.1800 - $127.3800) on Mon. Mar. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.33% (three month average) | RSI | 61 | Latest Price | $122.6900(-2.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.1% a day on average for past five trading days. | Weekly Trend | LGND advances 2.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(60%) IWO(57%) XBI(56%) IWC(54%) IWM(53%) | Factors Impacting LGND price | LGND will decline at least -1.665% in a week (0% probabilities). VXX(-15%) TLT(-15%) VIXM(-10%) UUP(-10%) IFRA(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.665% (StdDev 3.33%) | Hourly BBV | 0 () | Intraday Trend | -3.6% | | | |
|
5 Day Moving Average | $124.74(-1.64%) | 10 Day Moving Average | $122.3(0.32%) | 20 Day Moving Average | $120.55(1.78%) | To recent high | -20.1% | To recent low | 11.5% | Market Cap | $1.972b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |